Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Wright (Vancouver, Canada). Animal models of pulmonary hypertension in COPD. Annual Congress 2010 - Pulmonary vascular involvement in COPD

Member's Comments

No comment yet.

Related content which might interest you: Role of survivin in experimental models of pulmonary arterial hypertension Source: International Congress 2016 – Pulmonary hypertension and pulmonary embolism: from the bench to the bedside Year: 2016 Therapeutic potential of DMHCA for pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 LATE-BREAKING ABSTRACT: Pneumonectomy combined with SU5416: a novel animal model of pulmonary hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Animal models of pulmonary emphysema: a stereologist's perspective Source: Eur Respir Rev 2006; 15: 136-147 Year: 2006 Renal denervation reduces pulmonary vascular remodeling in two experimental pulmonary arterial hypertension models Source: International Congress 2015 – Pulmonary hypertension: new treatment insights Year: 2015 Formation of typical vascular lesions in a new experimental model of pulmonary arterial hypertension Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Erythropoietin recapitulates hemodynamic features of hypoxia-induced pulmonary hypertension in mice Source: International Congress 2016 – The nature of pulmonary hypertension Year: 2016 Role of the TrkA receptor in experimental severe pulmonary hypertension Source: International Congress 2015 – Pulmonary hypertension: promising small molecules Year: 2015 Dilatation reserve of pulmonary arteries at stages of COPD experimental model Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Imaging in assessment of out-of-proportion pulmonary hypertension in patients with COPD Source: Annual Congress 2010 - Parenchmya and bronchial carcinoma Year: 2010 Effects of intermittent hypoxia on pulmonary haemodynamics: animal models versus studies in humans Source: Eur Respir J 2005; 25: 173-180 Year: 2005 Genetics in pulmonary hypertension Source: Annual Congress 2012 - Contributing factors to pulmonary hypertension Year: 2012 Siah2 in pulmonary hypertension and right ventricular hypertrophy Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 A novel non-human primate model of cigarette smoke-induced chronic obstructive pulmonary disease Source: International Congress 2014 – Animal models: asthma, COPD and beyond Year: 2014 Therapeutic update of severe pulmonary hypertension in COPD Source: Annual Congress 2010 - Pulmonary vascular involvement in COPD Year: 2010 Comparison pulmonary rehabilitation efficiency in COPD patients between with and without pulmonary hypertension Source: International Congress 2014 – Latest insights in pulmonary rehabilitation Year: 2014 Obesity aggravates monocrotaline–induced pulmonary hypertension in female Zucker rats Source: International Congress 2015 – Pulmonary hypertension: novel insights into the biology of the disease Year: 2015 Human apyrase (APT102) treatment attenuates the development of severe pulmonary arterial hypertension (PAH) Source: Annual Congress 2013 –Pulmonary circulation: animal models and experimental treatments Year: 2013 Pathology of pulmonary hypertension Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease Year: 2014